Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | APOBEC3A and APOBEC3B deletion hybrid | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | vesicular acetylcholine transporter | 0.0647 | 0.6475 | 0.6475 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0 | 0.5 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.0712 | 0.7162 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0712 | 0.7162 | 1 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | 0.0647 | 0.6475 | 1 |
Onchocerca volvulus | 0.0365 | 0.3487 | 0.5386 | |
Onchocerca volvulus | 0.0286 | 0.2651 | 0.4094 | |
Echinococcus granulosus | vesicular acetylcholine transporter | 0.0647 | 0.6475 | 1 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0712 | 0.7162 | 0.5 |
Brugia malayi | hypothetical protein | 0.0286 | 0.2645 | 0.3694 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.2651 | 0.5 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0712 | 0.7162 | 0.5 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0235 | 0.0363 |
Schistosoma mansoni | vesicular acetylcholine transporter | 0.0647 | 0.6475 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.2645 | 0.4086 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0712 | 0.7162 | 0.5 |
Brugia malayi | hypothetical protein | 0.0365 | 0.3487 | 0.4869 |
Loa Loa (eye worm) | hypothetical protein | 0.0364 | 0.3474 | 0.485 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2282 | 0.3187 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0235 | 0.0363 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2282 | 0.3187 |
Brugia malayi | vesicular acetylcholine transporter unc-17 | 0.0647 | 0.6475 | 0.9041 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | 0.0647 | 0.6475 | 0.9041 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.2645 | 0.3694 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.2645 | 0.2645 |
Loa Loa (eye worm) | hypothetical protein | 0.0365 | 0.3487 | 0.4869 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0235 | 0.0329 |
Onchocerca volvulus | 0.0058 | 0.0235 | 0.0363 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1.61 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of small molecule APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493011, AID493024] | ChEMBL. | No reference |
IC50 (functional) | = 3.7 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of APOBEC3A DNA Deaminase Inhibitors via a A3G counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493011, AID493024] | ChEMBL. | No reference |
Potency (functional) | 0.9196 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.